Sandy Spring Bank’s Meridian Bioscience Inc VIVO Stock Holding History

Sandy Spring Bank’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	-$33	–	1215
2022 Q4	$33	Buy	+1	New	+$32	﹤0.01%	1130

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sandy Spring Bank's VIVO Position: Q1 2023 in Review

Sandy Spring Bank sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1 share — an estimated $33 sold.

Sandy Spring Bank first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $33 in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Sandy Spring Bank reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Sandy Spring Bank sold 1 Meridian Bioscience Inc share in Q1 2023, an estimated $33.
Sandy Spring Bank first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Sandy Spring Bank's Meridian Bioscience Inc position peaked at $33 in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Sandy Spring Bank's 13F filing for Q1 2023, filed 5 May 2023.